C2N Diagnostics Releases New Assay For Research On Dementia & Brain Health

C2N Diagnostics, which offers the PrecivityAD™ blood test as an aid to Alzheimer’s disease diagnosis, launched a new assay for brain health researchers: a high-resolution mass spectrometry-based plasma tau multi-analyte assay (p-tau MAA). The assay uses a small sample of blood and can measure different phosphorylated and nonphosphorylated forms of the tau protein. Abnormal tau and beta-amyloid proteins and several other factors play a vital role in Alzheimer’s-related brain changes. The assay can measure forms of phosphorylation at the tau217 and tau181 sites.

This research use only (RUO) assay is expected to . . .